STOCK TITAN

AstroNova (NASDAQ: ALOT) director exits stake at $29 in merger payout

(High)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

AstroNova, Inc. (ALOT) reported that director Yvonne Schlaeppi disposed of all reported equity interests in connection with a merger closing. On 2026-08-26, she disposed of 51,920.954 shares of common stock to the issuer at $29.00 per share under an Agreement and Plan of Merger. On the same date, two vested stock option grants for 5,000 shares each were cancelled pursuant to the Merger Agreement in exchange for cash payments equal to the difference between the $29.00 merger consideration and their respective exercise prices.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Schlaeppi Yvonne
Role Director
Type Security Shares Price Value
Disposition Stock Option (Right to Purchase) F2 5,000 $10.75 $54K
Disposition Stock Option (Right to Purchase) F3 5,000 $13.05 $65K
Disposition Common Stock F1 51,920.954 $29.00 $1.51M
Holdings After Transaction: Stock Option (Right to Purchase) — 0 shares (Direct); Common Stock — 0 shares (Direct)
Footnotes (3)
  1. F1. Disposed of pursuant to that certain Agreement and Plan of Merger, dated as of June 16, 2026, by and among AstroNova, Inc. (the "Company"), Orion Merger Parent, Inc. ("Parent"), and Orion MergerCo X, Inc., a wholly owned subsidiary of Parent (as it may be amended from time to time, the "Merger Agreement").
  2. F2. Stock Option originally granted on June 4, 2018, which became fully vested at the Company's 2019 Annual Meeting of Shareholders, and was cancelled on the Transaction Date as provided for in the Merger Agreement in exchange for an aggregate cash payment of $53,750, representing an amount equal to the product of: (i) the aggregate number of shares of the Company's common stock, par value $0.05 per share (the "Common Stock") subject to such Stock Option multiplied by (ii) the excess, if any, of $29.00 (the "Merger Consideration") over the per share exercise price under such Stock Option.
  3. F3. Stock Option originally granted on April 3, 2018, which became fully vested on April 3, 2019, and was cancelled on the Transaction Date as provided for in the Merger Agreement in exchange for an aggregate cash payment of $65,250, representing an amount equal to the product of: (i) the aggregate number of shares of the Company's common stock, par value $0.05 per share (the "Common Stock") subject to such Stock Option multiplied by (ii) the excess, if any, of $29.00 (the "Merger Consideration") over the per share exercise price under such Stock Option.
Common stock disposed 51,920.954 shares at $29.00 per share Disposition to issuer on 2026-08-26 under the Merger Agreement
Post-transaction common stock holdings 0.0000 shares Direct ownership after the 51,920.954-share disposition
First option cash payment $53,750 5,000-share option at $18.25 exercise price; paid 5,000 × ($29.00 − $18.25)
Second option cash payment $65,250 5,000-share option at $15.95 exercise price; paid 5,000 × ($29.00 − $15.95)
Merger Consideration $29.00 per share Cash consideration per share of AstroNova common stock in the merger
Option shares cancelled (each grant) 5,000 shares Two fully vested stock option grants cancelled on 2026-08-26
Option expiration dates 2028-06-04 and 2028-04-03 Original expiration dates of the two cancelled option grants
Agreement and Plan of Merger regulatory
"Disposed of pursuant to that certain Agreement and Plan of Merger, dated as of"
An Agreement and Plan of Merger is a formal document where two companies agree to combine into one, outlining how the process will happen. It’s like a step-by-step plan for merging, and it matters because it shows both sides have agreed on the details before the official transition takes place.
Merger Consideration financial
"excess, if any, of $29.00 (the "Merger Consideration") over the per share"
Merger consideration is the total payment a company or buyer offers to shareholders of a target company in exchange for combining the two businesses, and can include cash, shares in the surviving company, debt assumption, or a mix of these. Investors care because the form and amount affect the deal’s value, tax consequences, immediate cash received versus future ownership, and the risk and upside of holding new shares — similar to choosing between cash now or stock that could grow later.
Stock Option (Right to Purchase) financial
"Stock Option (Right to Purchase) originally granted on June 4, 2018"

FAQ

What did AstroNova (ALOT) director Yvonne Schlaeppi report in this Form 4?

She reported the disposition of 51,920.954 shares of AstroNova common stock at $29.00 per share and the cancellation of two fully vested stock option grants of 5,000 shares each, all in connection with a merger transaction.

How many AstroNova (ALOT) common shares did Yvonne Schlaeppi dispose of and at what price?

She disposed of 51,920.954 shares of AstroNova common stock at a price of $29.00 per share, as provided for under the Agreement and Plan of Merger among AstroNova, Orion Merger Parent, Inc., and Orion MergerCo X, Inc.

What happened to Yvonne Schlaeppi’s stock options in AstroNova (ALOT)?

Two fully vested stock option grants for 5,000 shares each were cancelled on 2026-08-26 under the Merger Agreement. Each was exchanged for cash equal to 5,000 times the excess of $29.00 over its per share exercise price.

What cash did Yvonne Schlaeppi receive for her cancelled AstroNova (ALOT) options?

One option grant generated an aggregate cash payment of $53,750, and the other generated $65,250. Each payment equals the number of option shares (5,000) multiplied by the excess of the $29.00 Merger Consideration over the option’s exercise price.

Does Yvonne Schlaeppi report any remaining AstroNova (ALOT) holdings after these transactions?

The Form 4 reports 0.0000 shares of common stock owned directly following the disposition of 51,920.954 shares, and the derivative summary shows no remaining reported stock option positions in this filing.

What is the Merger Consideration referenced for AstroNova (ALOT)?

The Merger Consideration is stated as $29.00 per share of AstroNova common stock. It is used to determine the cash received for both the common stock disposition and for the cancellation of the stock options under the Merger Agreement.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
X
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Schlaeppi Yvonne

(Last)(First)(Middle)
C/O ASTRONOVA, INC.
600 EAST GREENWICH AVENUE

(Street)
WEST WARWICK RHODE ISLAND 02893

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
AstroNova, Inc. [ ALOT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/26/2026D51,920.954D$29(1)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Purchase)$18.2508/26/2026D5,000 (2)06/04/2028Common Stock5,000$10.750D
Stock Option (Right to Purchase)$15.9508/26/2026D5,000 (3)04/03/2028Common Stock5,000$13.050D
Explanation of Responses:
1. Disposed of pursuant to that certain Agreement and Plan of Merger, dated as of June 16, 2026, by and among AstroNova, Inc. (the "Company"), Orion Merger Parent, Inc. ("Parent"), and Orion MergerCo X, Inc., a wholly owned subsidiary of Parent (as it may be amended from time to time, the "Merger Agreement").
2. Stock Option originally granted on June 4, 2018, which became fully vested at the Company's 2019 Annual Meeting of Shareholders, and was cancelled on the Transaction Date as provided for in the Merger Agreement in exchange for an aggregate cash payment of $53,750, representing an amount equal to the product of: (i) the aggregate number of shares of the Company's common stock, par value $0.05 per share (the "Common Stock") subject to such Stock Option multiplied by (ii) the excess, if any, of $29.00 (the "Merger Consideration") over the per share exercise price under such Stock Option.
3. Stock Option originally granted on April 3, 2018, which became fully vested on April 3, 2019, and was cancelled on the Transaction Date as provided for in the Merger Agreement in exchange for an aggregate cash payment of $65,250, representing an amount equal to the product of: (i) the aggregate number of shares of the Company's common stock, par value $0.05 per share (the "Common Stock") subject to such Stock Option multiplied by (ii) the excess, if any, of $29.00 (the "Merger Consideration") over the per share exercise price under such Stock Option.
/s/ Daniel Clevenger, by Power of Attorney08/26/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)